OBIO
Price:
$5.46
Market Cap:
$206.52M
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue S...[Read more]
Industry
Biotechnology
IPO Date
2020-08-04
Stock Exchange
NASDAQ
Ticker
OBIO
According to Orchestra BioMed Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 184.26M. This represents a change of -25.21% compared to the average of 246.38M of the last 4 quarters.
The mean historical Enterprise Value of Orchestra BioMed Holdings, Inc. over the last ten years is 217.27M. The current 184.26M Enterprise Value has changed 8.38% with respect to the historical average. Over the past ten years (40 quarters), OBIO's Enterprise Value was at its highest in in the March 2023 quarter at 534.03M. The Enterprise Value was at its lowest in in the December 2022 quarter at 123.59M.
Average
217.27M
Median
226.47M
Minimum
141.67M
Maximum
274.47M
Discovering the peaks and valleys of Orchestra BioMed Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 93.74%
Maximum Annual Enterprise Value = 274.47M
Minimum Annual Increase = -29.82%
Minimum Annual Enterprise Value = 141.67M
Year | Enterprise Value | Change |
---|---|---|
2023 | 274.47M | 93.74% |
2022 | 141.67M | -29.82% |
2021 | 201.87M | -19.60% |
The current Enterprise Value of Orchestra BioMed Holdings, Inc. (OBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
206.01M
5-year avg
217.27M
10-year avg
217.27M
Orchestra BioMed Holdings, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchestra BioMed Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orchestra BioMed Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Orchestra BioMed Holdings, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Orchestra BioMed Holdings, Inc. (OBIO)?
What is the 3-year average Enterprise Value for Orchestra BioMed Holdings, Inc. (OBIO)?
What is the 5-year average Enterprise Value for Orchestra BioMed Holdings, Inc. (OBIO)?
How does the current Enterprise Value for Orchestra BioMed Holdings, Inc. (OBIO) compare to its historical average?